共 26 条
[1]
GREENWALD R J, FREEMAN G J, SHARPE A H., The B7family revisited [J], Annual Review of Immunology, 23, 1, pp. 515-548, (2005)
[2]
YOSHIKO I, SERGOG T, MASAYA I, Et al., PD-1 inhibits antiviral immunity at the effector phase in the liver [J], The Journal of Experimental Medicine, 198, 1, pp. 39-50, (2003)
[3]
CALDERARO J, ROUSSESU B, AMDDEO G, Et al., Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features, Hepatology, 6, 64, pp. 2038-2046, (2016)
[4]
QU H X, ZHAO L P, ZHAN H S, Et al., Clinicopathological and prognostic significance of programmed cell death ligand 1 (pd-l1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis [J], Journal of Thoracic Disease, 8, 11, pp. 3197-3204, (2016)
[5]
GIUILIANA C, ROUSSEAU B, AMADDEO G, Et al., Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features, Hepatology Official Journal of the American Association for the Study of Liver Diseases, 6, 64, pp. 2038-2046, (2016)
[6]
MANSON Q F, NATALIE D, HOEVE T, Et al., Pd-1 and pd-l1 expression in male breast cancer in comparison with female breast cancer [J], Targeted Oncology, 13, 6, pp. 769-777, (2018)
[7]
FINKELMEIER F, CANIL O, TAL A, Et al., High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis [J], Cancer, 59, pp. 152-159, (2016)
[8]
TAN D, LI S, YI Q H, Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer [J], Cancer Biomarkers, 21, 2, pp. 287-297, (2018)
[9]
SHI SH H, WANG X, ZHAO M F, Et al., Sensing characteristics of period fiber grating functionalized with graphite oxide, Opt. Precision Eng, 27, 11, pp. 2305-2313, (2019)
[10]
SHI J S, YU Y H, WANG M J, Et al., Application of optical fiber biosensor in quantitative detection of HER3 antibody, Chinese Optics, 11, pp. 503-512, (2018)